Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc. (AUPH) Price Prediction & Forecast

$16.860

-0.457 (-2.71%)At close

Price Predictions

1-Day Price Prediction
+0.37%
1-Week Prediction
-0.03%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

Open in app to unlock longer-horizon forecasts.

Loading chart…

AUPH Prediction & Forecast by Similar Chart Analysis

Alphio's AUPH stock price prediction model matches the current Aurinia Pharmaceuticals Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $16.92 (+0.37%). The 1-week path is $16.85 (-0.03%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Should I Buy Aurinia Pharmaceuticals Inc. Stock?

Aurinia Pharmaceuticals Inc is a good buy right now due to its current price of $16.86, a strong gross margin of 92.12%, and a forward P/E ratio of 11.83, suggesting solid valuation. The recent acquisition of shares by the CEO for $12.5 million indicates confidence in the company's future. However, the main risk is the potential volatility indicated by an implied volatility of 54.66%.

AUPH stock price ended at $16.86 on Friday, after losing -2.71%

Aurinia Pharmaceuticals Inc. (AUPH) last closed at $16.86, losing -2.71%. These facts feed the 1-day and 1-week AUPH price prediction above.

Analyst Consensus

Aurinia Pharmaceuticals Inc. (AUPH): 5 buy, 0 hold, 0 sell. Outlook: Strong Buy.

Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.

Strong sellSellNeutralBuyStrong buy
Strong buy
Sell
0
Buy
5

Forecast Drivers

Aurinia Pharmaceuticals Inc. (AUPH) forecast drivers combine similar chart patterns, seasonality, and moving averages.

Similar patterns

Positive

Bullish

Seasonality

Positive

Bullish

SMA 20

Positive

Bullish

SMA 200

Positive

Bullish

Similar Chart Patterns

Stocks whose recent price path most closely matches AUPH, ranked by similarity.

Seasonality analysis for AUPH

Historically the probability of a positive October return for AUPH is 63.49%. December offers the highest probability of a positive month at 97.67%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

10-year price projections for AUPH

MonthMin PriceAvg PriceMax PricePotential ROI
Oct 2026$8.01$8.39$10.06-50.26%
Nov 2026$10.17$10.27$10.48-39.08%
Dec 2026$8.27$10.11$12.60-40.03%

In 2026, Aurinia Pharmaceuticals Inc. (AUPH) is projected to range from $8.01 to $12.60.

Aurinia Pharmaceuticals Inc. 2026 monthly forecast

Oct 2026 AUPH forecast
Potential ROI: -50.26%

In Oct 2026, Aurinia Pharmaceuticals Inc. is projected to average $8.39, with a low of $8.01 and high of $10.06.

Nov 2026 AUPH forecast
Potential ROI: -39.08%

In Nov 2026, Aurinia Pharmaceuticals Inc. is projected to average $10.27, with a low of $10.17 and high of $10.48.

Dec 2026 AUPH forecast
Potential ROI: -40.03%

In Dec 2026, Aurinia Pharmaceuticals Inc. is projected to average $10.11, with a low of $8.27 and high of $12.60.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading